A detailed history of Jamison Private Wealth Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 48,181 shares of BMY stock, worth $2.15 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
48,181
Previous 49,380 2.43%
Holding current value
$2.15 Million
Previous $2.68 Billion 25.28%
% of portfolio
0.33%
Previous 0.45%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$40.25 - $52.99 $48,259 - $63,535
-1,199 Reduced 2.43%
48,181 $2 Billion
Q1 2024

Apr 26, 2024

SELL
$47.98 - $54.4 $33,490 - $37,971
-698 Reduced 1.39%
49,380 $2.68 Billion
Q4 2023

Jan 17, 2024

SELL
$48.48 - $57.85 $263,052 - $313,894
-5,426 Reduced 9.78%
50,078 $2.57 Billion
Q3 2023

Jan 05, 2024

BUY
$57.89 - $64.73 $3.21 Million - $3.59 Million
55,504 New
55,504 $3.22 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $95B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Jamison Private Wealth Management, Inc. Portfolio

Follow Jamison Private Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jamison Private Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jamison Private Wealth Management, Inc. with notifications on news.